Exposure to a bacterial toxin during early life has emerged as the primary suspect in the doubling of early-onset bowel cancer cases across many nations over the last 20 years, members of the UK Parliament were told. While rising obesity rates and reduced physical activity contribute to the trend, researchers argue these known factors cannot explain the full scale of the increase.
Dr. Karl Smith-Byrne, a senior molecular epidemiologist at the University of Oxford, presented evidence to the Commons science and technology committee indicating that traditional risk factors such as smoking, alcohol consumption, and obesity account for only about half of the diagnoses. He stated he did not find it plausible that existing knowledge alone could explain the surge in cases among younger patients.

Colibactin Mutations Appear in Childhood
Scientists identified a substance called colibactin last year as a potential driver of the disease. Produced by certain variants of E. coli bacteria that live in the gut, the toxin causes specific hallmark mutations in cells. Data shows these mutations are three times more common in tumors from patients under 40 compared to those over 70.
Professor Mike Stratton of the Sanger Institute, who was not present at the hearing, noted that colibactin causes mutations in some children but not others. His research indicates that affected children can accumulate a mutational burden by age 10 that is similar to that of a 50-year-old. This early damage gives the colon or rectum a head start toward becoming cancerous.
Smith-Byrne, who is a survivor of early-onset rectal cancer himself, emphasized that the toxin likely acts during a sensitive period in early life. He described colibactin as the leading explanation for the current trends, though he acknowledged that more work is needed to confirm its direct role in driving the disease.

New Bacterial Variants Emerge Post-1960
Some experts suspect that specific variants of E. coli, which normally live harmlessly in the gut, have evolved in recent decades to produce colibactin. Professor Elio Riboli, a cancer epidemiologist at Imperial College London, told the committee that this toxin is essentially found in people born after 1960.
Riboli suggested that a mutation must have occurred in the bacteria, creating a new strain. Professor Helen Coleman from Queen’s University Belfast called colibactin the first new clue in quite some time. She warned that because the exposure likely happens in very early childhood or even before birth, studying the link is extremely difficult.

Bowel cancer remains the third most common cancer globally, representing about one in 10 of all cases. Although it is still far more common in people over 50, global figures show a steep rise in diagnoses among younger demographics. Riboli noted that while scientists hunt for unknown drivers, people should minimize known risks. He pointed out that while drinking and smoking are falling in the UK and US, obesity is rising. He estimated that applying known prevention strategies could prevent about 60% of current cancers, but society is not yet doing so.
Source: The Guardian

